
Compounds
The frontier — NAD+ precursors, senolytics, autophagy enhancers, and other niche bioactives at the leading edge of longevity research. Evidence is evolving fast; quality and bioavailability vary widely.
0
Compounds
0
High evidence
0
Featured
A clinical lens on compounds supplements
NAD precursors are the most-hyped, most-debated lane — promising biology, mixed clinical signal, expensive to run wrong.
Use this lane intentionally — high cost, ongoing debate, requires biomarker tracking to justify.
- →NAD-axis support in older adults
- →Pairing with senolytic protocols
- →Energy and metabolic context
- →Long-horizon longevity bets
- Biomarker rises are clear; outcomes are not
- IV vs oral debate is unresolved
- Sourcing quality varies wildly
- Cost vs benefit deserves honesty
- Am I tracking NAD or just spending money?
- Is the brand credible?
- Could I get more for less elsewhere?
Key benefits
- •NAD+ restoration and sirtuin activation
- •Senolytic clearance of senescent cells
- •Autophagy and metabolic flexibility
- •Glucose and lipid optimization
Key considerations
- •Long-term human data still emerging
- •Bioavailability varies wildly by source
- •Some require medical supervision (Rapamycin)
Ideal for
Notable compounds
All Compounds
Filter by Health Goal
Explore other categories
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation







